FDA clearance is a critical regulatory milestone that can significantly enhance a company's reputation and marketability of its products. For 3D Systems, this clearance not only validates the safety and efficacy of its VSP PEEK cranial implant but also opens up new market opportunities within the medical device sector. This is likely to have a positive impact on investor sentiment and the company's stock price in the short term, as it demonstrates 3D Systems' ability to innovate and expand its product portfolio in high-value areas.